Dose was 0.05mg/kg administered every other day.

  • treefrog@lemm.eeOP
    link
    fedilink
    arrow-up
    9
    arrow-down
    1
    ·
    1 year ago

    They demonstrated positive physiological charges. We don’t cut people up. I have mixed feelings about animal testing but without a longitudinal study on humans it is hard to demonstrate positive outcomes. Become of placebo as you mentioned.

    In other words, we don’t do this kind of study on humans because the subjects get cut up at the end.

    My hope is this will encourage more testing in humans. The data from this study is promising, even if it’s just rats…

    • eighthourlunch@kbin.social
      link
      fedilink
      arrow-up
      4
      ·
      1 year ago

      There have been plenty of studies on psilocybin with human subjects. None of them included vivisection or bisection. We have other ways of testing this sort of thing.

      • treefrog@lemm.eeOP
        link
        fedilink
        arrow-up
        4
        ·
        1 year ago

        Right.

        But the placebo affect makes positive outcomes harder to measure with microdosing, as you said.

        I think we do need more studies on humans, and while I don’t like that they killed animals I keep as pets, I do hope this will encourage more human studies.

        • django@discuss.tchncs.de
          link
          fedilink
          arrow-up
          3
          ·
          1 year ago

          Also the placebo effect is harder to tackle in this instance as people are often able to tell if they actually got psilocybin administered or not.